Research Library

    An independent reference library on stem cell therapy and cancer immunotherapy research.

    471 articles · 2 topics · 351 Stem Cell Research · 120 Cancer Immunotherapy

    Step 1 — Topic

    Step 2 — Category

    All 471 articles

    Bispecific Immunotherapy Beats Standard-of-Care in Advanced Biliary Tract Cancer, Phase 3 Trial Shows
    Research & Industry

    Bispecific Immunotherapy Beats Standard-of-Care in Advanced Biliary Tract Cancer, Phase 3 Trial Shows

    8 min read

    A large Phase 3 trial in China found that the dual-acting antibody ivonescimab, paired with chemotherapy, extended survival further than the current international standard of care in advanced biliary tract cancer — though only topline results have been released so far, and the win hasn't yet been replicated outside China.

    RegenMed Review Editorial TeamSeptember 3, 2026
    What Is Antibody-Drug Conjugate (ADC) Therapy, and How Is It Different From Immunotherapy?
    Fundamentals

    What Is Antibody-Drug Conjugate (ADC) Therapy, and How Is It Different From Immunotherapy?

    8 min read

    Antibody-drug conjugates are often described alongside immunotherapy in cancer news, but they work through a fundamentally different mechanism — delivering chemotherapy directly to tumor cells rather than directing the immune system to attack them. Here's what ADCs are, how three FDA-approved examples perform, and why the distinction matters.

    RegenMed Review Editorial TeamSeptember 3, 2026

    A Note on Sourcing

    Every feature article on regenmedreview carries a Sources block listing its references. Where the original source material included no external citations, that is stated explicitly rather than left blank.

    The Review Dispatch

    Our weekly briefing on the regenerative medicine landscape, for researchers, clinicians, and investors.

    regenmedreview

    regenmedreview is an independent reference library covering stem cell therapy and cancer immunotherapy research — compiled for researchers, clinicians, and patients exploring the field.

    The information on this site is for general educational purposes only and does not constitute medical advice. Regenerative medicine treatments discussed here may not be approved or available in all jurisdictions. Always consult a licensed physician before making treatment decisions.

    © 2026 regenmedreview. All rights reserved.Independent. Unaffiliated. Reader-supported.